Measurement of Glomerular Filtration Rate (GFR) in HIV Patients: Single-center Study Comparing the Accuracy of Estimators of GFR Versus Iohexol Plasma Clearance
NCT02522338 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 300
Last updated 2016-03-10
Summary
Cystatin C, a protease inhibitor produced by most nucleated cells, is freely filtered by the kidneys, and its plasma assay reflects the GFR.
Compare, in HIV patients, the predictive performance of 11 formula to estimate GFR based on assay plasma cystatin C with that of the MDRD formulas.
Conditions
Interventions
- DRUG
-
iohexol
10 ml de l'iohexol (300 mgI/ml)
Sponsors & Collaborators
-
Centre Hospitalier Universitaire de Saint Etienne
lead OTHER
Principal Investigators
-
Frédéric LUCHT, MD PhD · CHU de SAINT-ETIENNE
Study Design
- Allocation
- NA
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-02-28
- Primary Completion
- 2013-12-31
- Completion
- 2013-12-31
Countries
- France
Study Locations
More Related Trials
-
Pharmacokinetics Study of GSK1265744 in Subjects With Severe Renal Impairment
NCT02354937 ·Status: COMPLETED ·Phase: PHASE1
-
Immune and Viral Status of HIV-Infected Patients After Stopping Combination Antiretroviral Therapy
NCT00001899 ·Status: COMPLETED
-
Dynamics of Drug Resistance-associated Mutations in HIV-1 DNA Reverse Transcriptase Clearance During Effective Antiretroviral Therapy
NCT04448158 ·Status: COMPLETED
-
Same-Day HIV Testing and Treatment Initiation to Improve Retention in Care
NCT01900080 ·Status: UNKNOWN ·Phase: NA
-
Oral Auranofin for Reduction of Latent Viral Reservoir in Patients With HIV Infection
NCT02176135 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Renal Integrase Study
NCT02351908 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Drug Therapy and Co-Morbidities on the Development of Renal Impairment in HIV-Infected Patients
NCT00551655 ·Status: COMPLETED
-
Measurement of Plasma and Intracellular Concentrations of Raltegravir
NCT01214486 ·Status: COMPLETED ·Phase: NA
-
Dolutegravir Renal Impairment Study
NCT01353716 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of Calcineurin & mTOR Inhibitors in HIV-1 Infected Kidney Transplant Recipients After Switch to BIC/FTC/TAF
NCT04993872 ·Status: UNKNOWN ·Phase: PHASE4
-
Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Regimen Versus Boosted Protease Inhibitor (bPI) Along With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Regimen in Virologically-Suppressed, HIV-1 Infected Participants
NCT02269917 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Dolutegravir Removed by Hemodialysis in HIV-infected Patients With End-stage Renal Disease
NCT02487706 ·Status: COMPLETED ·Phase: PHASE4
-
Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infection
NCT01231685 ·Status: COMPLETED ·Phase: PHASE2
-
Raltegravir Added to Stable HAART in HIV-1 Infected Subjects With Viral Suppression and Low CD4 Recovery
NCT00562510 ·Status: TERMINATED ·Phase: PHASE3
-
Safety and Efficacy Clinical Study of KL-HIV-Tri01 in the Treatment of HIV Infected Subjects
NCT06117657 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Pilot Study of Raltegravir Switch to Resolve Tenofovir Induced Proteinuria
NCT01044771 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance
NCT04150068 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Screening Protocol To Determine Eligibility For Studies Of The Chemokine Coreceptor 5 (CCR5) Antagonist GW873140
NCT00123890 ·Status: TERMINATED ·Phase: PHASE3
-
Kidney Transplant for HIV-Infected Patients in Renal Failure
NCT00009009 ·Status: COMPLETED ·Phase: PHASE2
-
Long-Term Effects of HAART in Youth With Stronger Immune Systems Versus Youth With Weaker Immune Systems
NCT00001097 ·Status: COMPLETED
-
Sequential HIV Therapy in Treatment Resistant HIV-1 Infected Patients
NCT00128908 ·Status: TERMINATED ·Phase: PHASE4
-
A Comparison of Two Tests for Anti-HIV Drug Resistance
NCT00006490 ·Status: COMPLETED
-
Efficacy and Tolerance of the Switch From Enfuvirtine to Raltegravir in Antiretroviral Therapy Regimen in HIV Patients With Undetectable Viral Load
NCT00454337 ·Status: COMPLETED ·Phase: PHASE3
-
ALternative TEnofovir Dosing in Adults With Moderate Renal Function Impairment
NCT01671982 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Two Methods of Determining When to Begin or Change Anti-HIV Treatment
NCT00001069 ·Status: TERMINATED